We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Edwards Lifesciences Corporation (EW) - free report >>
iShares Biotechnology ETF (IBB) - free report >>
SPDR S&P Biotech ETF (XBI) - free report >>
ALPS Medical Breakthroughs ETF (SBIO) - free report >>
Navigating The Healthcare Industry: Science Fiction Turns to Reality
The healthcare industry is moving quick these days with the constant breakthroughs in science from gene editing to the robotics that help with todays surgeries. Kevin Cook joins us to help break it all down by running though his top 4 mega trends that are shaping the industry. He shares insights on specific companies like Edward Life Science (EW - Free Report) , GW Pharmaceuticals and also a wide array of ETFs. With science fiction becoming reality now a days, we wanted to learn what it takes to find a winner. The industry should only continue to grow with the population and growing technology. We thought why not try and figure out how to invest in this expanding sector. To get recent Zacks video updates, be sure to subscribe to our Youtube channel and participate by leaving any comments or questions.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>